by Team Small News | Aug 9, 2025 | Pfizer, Pharma, Zydus
Zydus Lifesciences, a leading pharmaceutical company, has received approval from Health Canada for its smoking cessation drug, ZDS-Varenicline. This approval marks a significant milestone for the company, as it expands its presence in the Canadian market....
by Team Small News | Jul 26, 2025 | Pharma, Zydus
Zydus Lifesciences Limited, a leading pharmaceutical company, has announced its expansion into a new market, marking a significant milestone in its growth journey. This strategic move is expected to open up new avenues for revenue growth and increase the...
by Team Small News | Jul 9, 2025 | Pharma, Zydus
In a significant development, the Bombay High Court has dismissed a pre-emptive lawsuit filed by Indian pharmaceutical company Zydus Cadila against Swiss multinational company Roche nearly a decade ago. The lawsuit related to Zydus Cadila’s biosimilar version of...
by Team Small News | Jun 9, 2025 | Pharma, Zydus
Agenus Inc., a clinical-stage immuno-oncology company, has partnered with Zydus Lifesciences, a global healthcare company, in a $141 million deal to expand access to its investigational therapies, botensilimab and balstilimab. This partnership aims to accelerate the...
by Team Small News | Jun 7, 2025 | Pharma, Zydus
Agenus Inc., a clinical-stage immuno-oncology company, has partnered with Zydus Lifesciences, a leading Indian pharmaceutical company, in a deal worth up to $141 million to expand access to two of its key pipeline assets, botensilimab and balstilimab. This...
by Team Small News | May 29, 2025 | Pharma, Zydus
Zydus Lifesciences Ltd. has announced that its experimental drug, Usnoflast, has been granted Fast Track Designation by the US Food and Drug Administration (US FDA) for the treatment of amyotrophic lateral sclerosis (ALS). This designation is given to drugs that treat...